Guangzhou Hexin Instrument (688622)

Search documents
科创板晚报|联影医疗光子计数能谱CT获批上市 南新制药拟收购未来医药标的资产组
Xin Lang Cai Jing· 2025-08-26 12:59
Group 1 - The State Council emphasizes increasing financial and fiscal support for the artificial intelligence (AI) sector, aiming for over 70% penetration of new intelligent terminals and agents by 2027 [2][3] - By 2030, AI is expected to significantly contribute to high-quality economic development, with over 90% penetration of new intelligent applications [2] - The government plans to enhance the legal and regulatory framework for AI, including risk management and investment exit mechanisms [2][4] Group 2 - The National Development and Reform Commission (NDRC) will coordinate efforts to implement the AI action plan, ensuring local adaptation and avoiding superficial compliance [4] - The NDRC aims to foster a complete AI application service chain and promote the development of intelligent native technologies and services [4] - The NDRC will also support open-source ecosystem development to enhance international influence [4] Group 3 - The National Energy Administration acknowledges that the rapid growth of electric vehicle and AI sectors is driving increased electricity demand, which is reshaping energy consumption patterns [5][6] - Data indicates a 34.3% year-on-year increase in electricity consumption for new energy vehicle manufacturing in 2024, and a 20.5% increase for internet and related services [5][6] Group 4 - The new generation of the Chinese operating system, Galaxy Kirin V11, has been officially released, featuring significant improvements in architecture, security, and ecosystem compatibility [6] - Galaxy Kirin has achieved over 16 million deployments and is compatible with major domestic CPUs and GPUs, supporting various national projects [6] Group 5 - ByteDance has raised its option price to $200.41 per share, marking a significant increase from $189.9 earlier this year, reflecting a fivefold increase since 2019 [6] Group 6 - Aliyun's Baolian has announced a price reduction for certain model context caching, lowering the cost from 40% to 20% of the input token price when cache hits occur [7] Group 7 - Union Medical has received a medical device registration certificate for China's first photon counting spectral CT, marking a significant advancement in medical technology [8] - Nanjing New Pharmaceutical plans to acquire assets from Future Medicine for up to 480 million yuan, which is expected to constitute a major asset restructuring [9] - Biyimi plans to acquire 100% of Shanghai Xingan Semiconductor for 295 million yuan to enhance its core business and technology capabilities [10]
禾信仪器(688622) - 股东询价转让定价情况提示性公告
2025-08-26 08:31
证券代码:688622 证券简称:禾信仪器 公告编号:2025-050 广州禾信仪器股份有限公司 股东询价转让定价情况提示性公告 昆山市国科创业投资有限公司保证向广州禾信仪器股份有限公司(以下简称 "公司")提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏,并 对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 一、本次询价转让初步定价 (一)经向机构投资者询价后,初步确定的转让价格为 84.16 元/股。 (二)参与本次询价转让报价的机构投资者家数为 12 家,涵盖了基金管理 公司、合格境外机构投资者、证券公司、私募基金管理人等专业机构投资者。参 与本次询价转让报价的机构投资者合计有效认购股份数量为 1,640,000 股,对应 的有效认购倍数为 1.3 倍。 (三)本次询价转让拟转让股份已获全额认购,初步确定受让方为 10 家机 构投资者,拟受让股份总数为 1,303,612 股。 二、风险提示 1 根据 2025 年 8 月 26 日询价申购情况,初步确定的本次询价转让价格为 84.16 元/股。 受让方通过询价转让受 ...
禾信仪器:询价转让价格为84.16元/股
Mei Ri Jing Ji Xin Wen· 2025-08-26 08:11
每经AI快讯,8月26日,禾信仪器(688622.SH)公告称,根据2025年8月26日询价申购情况,初步确定的 本次询价转让价格为84.16元/股。参与询价转让报价的机构投资者家数为12家,合计有效认购股份数量 为1,640,000股,对应有效认购倍数为1.3倍。本次询价转让拟转让股份已获全额认购,初步确定受让方 为10家机构投资者,拟受让股份总数为1,303,612股。 ...
禾信仪器股东拟询价转让 2021上市募3.1亿其后连亏3年
Zhong Guo Jing Ji Wang· 2025-08-26 03:13
Core Viewpoint - HeXing Instruments (688622.SH) is undergoing a share transfer plan initiated by a major shareholder, Kunshan Guoke, due to funding needs, while the company reported a significant decline in revenue and net profit for 2024 [1][2]. Group 1: Share Transfer Plan - HeXing Instruments plans a share transfer of 1,303,612 shares, representing 1.85% of the total share capital, initiated by Kunshan Guoke [1]. - The transfer will be conducted through a non-public method, organized by China International Capital Corporation (CICC), and the shares cannot be transferred by the buyer within six months [1]. - Kunshan Guoke is a shareholder holding more than 5% of the company but is not the controlling shareholder or part of the management [1]. Group 2: Financial Performance - In 2024, HeXing Instruments reported a revenue of 203 million yuan, a year-on-year decrease of 44.70% [1]. - The net profit attributable to shareholders was -45.99 million yuan, an improvement from -96.11 million yuan in the previous year [1]. - The net profit after deducting non-recurring losses was -63.10 million yuan, compared to -111 million yuan in the prior year [1]. - The net cash flow from operating activities was -8.21 million yuan, an improvement from -36.37 million yuan year-on-year [1]. Group 3: Historical Context - In 2022, HeXing Instruments recorded a net profit of -63.33 million yuan and a net profit of -92.18 million yuan after excluding non-recurring losses [2]. - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 13, 2021, with an initial share issuance of 17.50 million shares at a price of 17.70 yuan per share [2]. - The total funds raised from the initial public offering (IPO) amounted to 310 million yuan, with a net amount of 273 million yuan after deducting issuance costs [2].
禾信仪器8月25日获融资买入1433.56万元,融资余额1.59亿元
Xin Lang Cai Jing· 2025-08-26 01:29
融资方面,禾信仪器当日融资买入1433.56万元。当前融资余额1.59亿元,占流通市值的2.02%,融资余 额超过近一年50%分位水平,处于较高位。 融券方面,禾信仪器8月25日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0.00元,超过近一年90%分位水平,处于高位。 资料显示,广州禾信仪器股份有限公司位于广东省广州市黄埔区新瑞路16号,成立日期2004年6月24 日,上市日期2021年9月13日,公司主营业务涉及质谱仪研发、生产、销售及技术服务。主营业务收入 构成为:数据分析服务30.64%,环保在线监测仪器28.87%,技术运维服务23.00%,实验室分析仪器 10.08%,其他4.41%,医疗仪器及耗材3.00%。 截至6月30日,禾信仪器股东户数2531.00,较上期增加6.08%;人均流通股27840股,较上期减少 5.10%。2025年1月-6月,禾信仪器实现营业收入5281.57万元,同比减少48.88%;归母净利润-1745.96万 元,同比增长20.86%。 分红方面,禾信仪器A股上市后累计派现1189.96万元。近三年,累计 ...
禾信仪器: 股东询价转让计划书
Zheng Quan Zhi Xing· 2025-08-25 16:53
Key Points - The shareholder Kunshan Guoke intends to transfer 1,303,612 shares of Guangzhou Hexin Instrument Co., Ltd., representing 1.85% of the total share capital [1][2] - The transfer will be conducted through a non-public inquiry transfer, and the shares cannot be transferred by the acquirer within six months after the acquisition [1][2] - The transfer is motivated by the shareholder's need for funds [3][4] Shareholder Information - Kunshan Guoke is a shareholder holding more than 5% of the company's shares but is not the controlling shareholder or a member of the board [1][2] - As of August 25, 2025, Kunshan Guoke holds 20.39% of the total shares before the transfer [3] Transfer Details - The transfer price will be determined based on the average trading price of the company's shares over the 20 trading days prior to the issuance of the subscription invitation, with a minimum price set at 70% of that average [4] - The transfer will be organized by China International Capital Corporation (CICC), which will prioritize bids based on price, quantity, and submission time [4]
禾信仪器: 关于2023年限制性股票与股票期权激励计划首次授予股票期权第一个行权期行权结果暨股份变动公告
Zheng Quan Zhi Xing· 2025-08-25 16:52
年 8 月 24 日期间,累计行权并完成股份过户登记数量为 398,757 股,占本次可行权总量的 100%。 ?本次行权股票上市流通时间:公司本次行权采用自主行权模式,激励对象行权所得股票 于行权日(T 日)后的第一个交易日(T+1 日)到达股票账户,并于第二个交易日(T+2 日) 上市交易。 一、本次股票期权行权的决策程序及信息披露 (1)2023年8月4日,公司召开第三届董事会第十六次会议,审议通过了《关于公司<2023 年限制性股票与股票期权激励计划(草案)> 及其摘要的议案》《关于公司<2023年股权激励 计划实施考核管理办法>的议案》《关于提请股东大会授权董事会办理公司股权激励相关事宜 的议案》等议案。同日,公司独立董事就本次激励计划相关议案发表了明确同意的独立意见。 证券代码:688622 证券简称:禾信仪器 公告编号:2025-049 广州禾信仪器股份有限公司 关于2023年限制性股票与股票期权激励计划首次授予股票期权第一个 行权期行权结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要 ...
禾信仪器: 中国国际金融股份有限公司关于广州禾信仪器股份有限公司股东向特定机构投资者询价转让股份相关资格的核查意见
Zheng Quan Zhi Xing· 2025-08-25 16:52
中国国际金融股份有限公司 关于广州禾信仪器股份有限公司 股东向特定机构投资者询价转让股份 相关资格的核查意见 企业名称 昆山市国科创业投资有限公司 统一社会信用代码 913205837311608172 类型 有限责任公司 成立日期 2001 年 8 月 31 日 住所 昆山市玉山镇登云路 258 号汇金财富广场 1 号楼 701 室 中国国际金融股份有限公司(以下简称"中金公司")受广州禾信仪器股份有限 公司(以下简称"禾信仪器")股东昆山市国科创业投资有限公司(以下简称"昆山 国科""出让方")委托,组织实施本次禾信仪器股东向特定机构投资者询价转让 (以下简称"本次询价转让")。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创板上 市公司持续监管办法(试行)》《上海证券交易所科创板股票上市规则》《上海证券 交易所科创板上市公司自律监管指引第 4 号——询价转让和配售》(以下简称"《询 价转让和配售指引》")等相关规定,中金公司对参与本次询价出让方的相关资格进 行了核查。 二、关于参与本次询价转让股东相关资格的核查情况 本次询价转让的委托情况、出让方相关资格的核查情况及核查意见如下: ( ...
禾信仪器:本次拟询价转让1.85%股份
Ge Long Hui· 2025-08-25 12:03
Core Viewpoint - Hexin Instruments (688622.SH) plans to participate in a pre-IPO shareholder inquiry transfer, with Kunshan Guoke as the selling shareholder [1] Group 1: Shareholder Transfer Details - The total number of shares to be transferred is 1,303,612, which represents 1.85% of the company's total share capital [1] - This inquiry transfer is a non-public transfer and will not be conducted through centralized bidding or block trading, thus not classified as a secondary market reduction [1] - The acquiring party is restricted from transferring the shares for a period of six months after the acquisition [1]
禾信仪器(688622.SH):本次拟询价转让1.85%股份
Ge Long Hui A P P· 2025-08-25 11:34
Group 1 - The core point of the article is that Hexin Instruments (688622.SH) plans to participate in a pre-IPO share transfer, with Kunshan Guoke as the selling shareholder [1] - The total number of shares to be transferred is 1,303,612, which represents 1.85% of the company's total share capital [1] - This share transfer is a non-public transfer and will not be conducted through centralized bidding or block trading, meaning it does not fall under secondary market reductions [1] - The acquiring party is restricted from transferring the shares for a period of six months after the acquisition [1]